- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03888339
Influence of Abutment Shape on Peri-implant Marginal Bone Loss
June 22, 2022 updated by: David Peñarrocha Oltra, University of Valencia
Influence of Different Abutment Shape on Peri-implant Marginal Bone Loss: A Randomized Clinical Trial.
A study designed as a randomized controlled trial of parallel group design will be conducted at the Dental clinic of the University of Valencia to evaluate the influence of 2.5 mm high abutments with different shapes (commercially available high abutments vs high abutments with modified shape to imitate short abutments) on peri-implant bone loss around bone level implants with platform switching in partially edentulous patients that require a fixed rehabilitation supported by two implants in the posterior mandible or maxilla and in fixed rehabilitation supported by one implant in the anterior mandible or maxilla.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A study designed as a randomized controlled trial of parallel group design will be conducted at the Dental clinic of the University of Valencia to evaluate the influence of 2.5 mm high abutments with different shapes (commercially available high abutments vs high abutments with modified shape to imitate short abutments) on peri-implant bone loss around bone level implants with platform switching in partially edentulous patients that require a fixed rehabilitation supported by two implants in the posterior mandible or maxilla and in fixed rehabilitation supported by one implant in the anterior mandible or maxilla (from premolar to premolar).
Study Type
Interventional
Enrollment (Actual)
46
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Valencia, Spain, 46010
- Clínica Odontológica de la Universitat de Valencia, Fundación Lluis Alcanyis
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Any subject requiring two implants in the posterior mandible or maxilla, being at least 18 years old and able to sign an informed consent. Final patient inclusion will be made after flap elevation during the implant placement surgery to be able to confirm the presence of a vertical thickness ≥ 3mm of keratinized soft tissues.
- Bone volumes should allow the placement of implants at least 8 mm long (i.e, 10 mm bone height to the inferior alveolar nerve) and 4.2 mm wide (7 mm wide bone crest) without bone regeneration procedures.
- Patients will be grouped into: 1) non smokers; 2) light smokers (≤ 10 cigarettes/day); 3) heavy smokers (≥ 11 cigarettes/day)
Exclusion Criteria:
- Patients unable to commit to follow-up.
- General contraindications to implant surgery.
- Immuno-suppressed/immune-compromised patients.
- Patients irradiated in the head and/or neck.
- Uncontrolled diabetes.
- Pregnancy or lactation.
- Untreated periodontal disease.
- Poor oral hygiene and motivation.
- Addiction to alcohol or drugs.
- Psychiatric problems and/or unrealistic expectations.
- Patients with an acute infection (abscess) or suppuration in the site intended for implant placement.
- Patients treated or under treatment with intravenous amino-bisphosphonates.
- Patients referred only for implant placement if the follow-up cannot be done at the treatment center.
- Patients participating in other studies, if the present protocol could not be fully adhered to.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control group - Commercially available high abutments
Commercially available 2.5mm high abutments
|
Patients will be randomly selected for the commercially available high abutments option.
Two or three implants will be placed following the drilling protocol suggested by the manufacturer.
Implants will be placed 0.5mm subcrestal.
Once the implants have been placed, periapical radiographs and clinical pictures will be taken.
Implants will be uncovered 10 weeks after being placed.
After performing the incision and elevation a minimal flap, conventional high transmucosal abutments will be screwed using the torque recommended by the manufacturer.
Once the abutments have been screwed, periapical radiographs and clinical pictures will be taken.
The abutments will not be unscrewed thereafter throughout the study.
|
|
Experimental: Test group - Modified shape abutments
Modified shape 2.5mm high abutments (imitating the shape of 0.5mm short abutments)
|
Patients will be randomly selected for the modified shape abutments option.
Two or three implants will be placed following the drilling protocol suggested by the manufacturer.
Implants will be placed 0.5mm subcrestal.
Once the implants have been placed, periapical radiographs and clinical pictures will be taken.
Implants will be uncovered 10 weeks after being placed.
After performing the incision and elevation a minimal flap, modified high transmucosal abutments will be screwed using the torque recommended by the manufacturer.
Once the abutments have been screwed, periapical radiographs and clinical pictures will be taken.
The abutments will not be unscrewed thereafter throughout the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peri-implant bone level changes
Time Frame: 12 months after implant loading
|
Assessed on digital periapical radiographs taken with the paralleling technique at delivery of crowns (implant loading) and 12 months afterwards.
|
12 months after implant loading
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Implant survival rate
Time Frame: 12 months after implant loading
|
% of implants in function
|
12 months after implant loading
|
|
Probing pocket depth
Time Frame: 12 months after implant loading
|
Measured in millimeters with a millimetered periodontal probe
|
12 months after implant loading
|
|
Bleeding on probing
Time Frame: 12 months after implant loading
|
Positive or negative bleeding after having probed with a millimetered periodontal probe
|
12 months after implant loading
|
|
Peri-implant soft tissue recession
Time Frame: 12 months after implant loading
|
Measured in millimeters with a millimetered periodontal probe
|
12 months after implant loading
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 5, 2018
Primary Completion (Actual)
May 31, 2022
Study Completion (Actual)
May 31, 2022
Study Registration Dates
First Submitted
December 11, 2018
First Submitted That Met QC Criteria
March 22, 2019
First Posted (Actual)
March 25, 2019
Study Record Updates
Last Update Posted (Actual)
June 24, 2022
Last Update Submitted That Met QC Criteria
June 22, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H1524219380739
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bone Resorption
-
Aristotle University Of ThessalonikiUniversity Paul Sabatier of ToulouseRecruiting
-
Second Affiliated Hospital, School of Medicine,...CompletedAlveolar Bone ResorptionChina
-
Nourhan M.AlyAlexandria UniversityCompletedMandibular Bone ResorptionEgypt
-
Marmara UniversityCompleted
-
Egyptian Russian UniversityCompletedAlveolar Bone ResorptionEgypt
-
Cairo UniversityUnknown
-
Cairo UniversityUnknown
-
International Advanced Dentistry, LisbonUnknownBone Loss | Alveolar Bone Resorption
-
University of LouisvilleBioHorizons, Inc.CompletedAlveolar Bone ResorptionUnited States
-
Al-Azhar UniversityActive, not recruitingAlveolar Bone ResorptionEgypt
Clinical Trials on Commercially available high abutments placement
-
Gulhane School of MedicineUniversity Hospital, Ghent; Szeged University; University Clinical Centre of... and other collaboratorsCompletedColorectal Disorders | Colorectal SurgeryTurkey
-
University of Colorado, DenverColorado State University; Institute of Cannabis Research, Colorado State University...CompletedAlcohol Use Disorder | Cannabis UseUnited States
-
AtriCure, Inc.RecruitingPostural Tachycardia Syndrome | Inappropriate Sinus TachycardiaUnited States, Belgium
-
MedtronicNeuroTerminatedPain, Chronic | Pain, IntractableUnited States
-
University of the PacificCompletedCardiovascular DiseasesUnited States
-
Massachusetts General HospitalHarvard School of Public Health (HSPH)Completed
-
MedtronicRecruitingChronic Pain | Intractable PainUnited States
-
Universitair Ziekenhuis BrusselCompletedInfertility, FemaleBelgium
-
Direct Flow Medical, Inc.UnknownAortic Valve StenosisUnited States